Global Artificial Intelligence (AI) in Precision Medicine Market Growth (Status and Outlook) 2023-2029

Global Artificial Intelligence (AI) in Precision Medicine Market Growth (Status and Outlook) 2023-2029

The global Artificial Intelligence (AI) in Precision Medicine market size is projected to grow from US$ 1756 million in 2022 to US$ 5774.5 million in 2029; it is expected to grow at a CAGR of 18.5% from 2023 to 2029.

United States market for Artificial Intelligence (AI) in Precision Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Artificial Intelligence (AI) in Precision Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Artificial Intelligence (AI) in Precision Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Artificial Intelligence (AI) in Precision Medicine players cover Atomwise Inc, Alphabet Inc., AstraZeneca, BioXcel Therapeutics Inc., Berg LLC, Enlitic Inc., GE Healthcare, Insilico Medicine and Intel Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Targeting the appropriate medications to the appropriate patients at the appropriate times is the aim of precision medicine. Precision medicine has already produced significant new findings and FDA-approved therapies that are tailored to a person’s unique traits, such as their genetic makeup or the genetic profile of their tumor. Molecular testing is frequently administered to patients with different types of cancer as part of patient care, allowing medical professionals to choose therapies that raise survival rates and lower the risk of side effects.

LPI (LP Information)' newest research report, the “Artificial Intelligence (AI) in Precision Medicine Industry Forecast” looks at past sales and reviews total world Artificial Intelligence (AI) in Precision Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence (AI) in Precision Medicine sales for 2023 through 2029. With Artificial Intelligence (AI) in Precision Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence (AI) in Precision Medicine industry.

This Insight Report provides a comprehensive analysis of the global Artificial Intelligence (AI) in Precision Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Intelligence (AI) in Precision Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Intelligence (AI) in Precision Medicine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence (AI) in Precision Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence (AI) in Precision Medicine.

This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence (AI) in Precision Medicine market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Hardware
Software and Service

Segmentation by application
Oncology
Neurology
Cardiology
Respiratory
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Atomwise Inc
Alphabet Inc.
AstraZeneca
BioXcel Therapeutics Inc.
Berg LLC
Enlitic Inc.
GE Healthcare
Insilico Medicine
Intel Corporation
IQVIA
IBM Corporation
Modernizing Medicine Inc.
NVIDIA Corporation
Microsoft Corporation
Novo Nordisk A/S
Sanofi
Sensely Inc.
Tempus
Zephyr AI

Please note: The report will take approximately 2 business days to prepare and deliver.